India IPO wave
India’s IPO pipeline is heating up with roughly a ₹10,000 crore wave of deals set to list in the coming week — analysts warn that volume could pressure valuations and liquidity. One notable fintech: Turtlemint Fintech is planning a May IPO to raise over ₹218 crore earmarked for cloud infrastructure and tech growth, feeding optimism about a broader tech‑IPO resurgence (niftytrader.in) (x.com).
SEBI issued final observation letters between March 25 and March 27, 2026, clearing six companies — SAEL Industries, Vishvaraj Environment, Symbiotec Pharmalab, Prasol Chemicals, NoPaperForms Solutions and Shah Investor’s Home — to move ahead with IPO filings. (economictimes.indiatimes.com) SAEL’s draft offer shows a proposed ₹4,575 crore issue comprising a ₹3,750 crore fresh issue and a ₹825 crore offer‑for‑sale by Norfund. (financialexpress.com) Vishvaraj Environment’s DRHP proposes a ₹2,250 crore issue made up of a ₹1,250 crore fresh offer and a ₹1,000 crore OFS, while Symbiotec Pharmalab’s filing lists a ₹2,180 crore raise with a ₹150 crore fresh issue and a ₹2,030 crore OFS. (chittorgarh.com) Prasol Chemicals has filed for a ₹500 crore book‑built issue (₹80 crore fresh, ₹420 crore OFS), and NoPaperForms Solutions and Shah Investor’s Home were specifically recorded as receiving SEBI’s observation letters on March 25 and March 27, 2026, respectively. (ipocentral.in) Market commentators point to the large share of OFS and clustered timelines as a source of incremental secondary‑market supply during anchor allocations and listing cycles, a dynamic flagged by strategists including Axis Mutual Fund’s Ashish Gupta as likely to constrain near‑term upside. (niftytrader.in) Turtlemint’s draft filing shows planned use of proceeds that includes ₹193.04 crore for technology and product development and ₹25.64 crore for cloud and server infrastructure, and ICICI Securities is named as the book‑running lead manager in its IPO paperwork. (iposcanner.ai) SEBI’s observation letters for DRHPs typically remain valid for 12 months (with confidential‑filing timelines allowing up to 18 months in some cases), giving the newly approved issuers a defined window to finalize price bands and launch dates. (sebi.gov.in)